Spinal Muscular Atrophy Outcome Measures Workshop (English Language)
Earlier this year, NMD4C, MDC and Quebec SMA Network hosted the first interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal Muscular Atrophy (SMA).
To complement this training session, the NMD4C will be hosting an English-language interactive training workshop on standardizing assessment practices in SMA outcome measures.
This workshop will be taking place the day before the Allied Professionals Forum in Montreal.
Please ensure you register before the deadline of June 18th, 2024.
Please ensure that you meet the eligibility criteria:
- Must be a physiotherapist or occupational therapist at a Canadian institution/clinic evaluating patients of any age with SMA.
- Must be a NMD4C member.
Disclaimer:
We have a limited number of seats available for this workshop (in-person only). Participants will be selected based on considerations related to geography, case load and clinic needs. There is a discounted hotel room rate as part of the Allied Professionals Forum meeting and financial support for travel and accommodations will be provided (details to follow upon acceptance).
Read next...
NMD4C Host Inaugural Basic Research Summer School
Over May 27-28 2024, the NMD4C animal and cell-based research team hosted the first-ever annual basic research summer school for neuromuscular research trainees at McGill University in Montréal, QC.
NMD4C Investigator Dr. Reshma Amin Leads Successful CIHR Grant Application to Establish a Framework for Real-World Evidence for Canadian Neuromuscular Diseases
Real-World Evidence for Canadian Neuromuscular Disease: Establishing a Framework for National Integration of Patient Reported Outcomes, Clinical Registry Data, Healthcare Utilization and Healthcare Associated Costs The NMD4C is excited to share that network investigator Dr. Reshma Amin has been awarded funding from the CIHR to establish a framework for real-world evidence (RWE) for Canadian…
NMD4C Launch Survey to Assess Familiarity and Experience in Outcome Measures in NMDs
As we anticipate novel treatments for other neuromuscular conditions, we would like to understand your familiarity and experience with the outcome measures in clinical trials underway or for treatments for NMDs approved in other jurisdictions through a short survey.
Dr. Cynthia Gagnon Receives 2024 Steinert Award, IDMC-15 Meeting to Take Place in Saguenay
We are pleased to share that NMD4C steering committee member Dr. Cynthia Gagnon was honoured with a Steinert Award at the recent International Myotonic Dystrophy Consortium Meeting (IDMC-14) in Nijmegen, Netherlands!
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
